In patents with type 2 diabetes, weekly injections with exenatide controlled hemoglobin A1c levels more effectively than did daily glargine over a 3-year period, investigators reported...

Field of Interest: Endocrinology

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.